The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five - year retrospective study
Open accessAbstract
BACKGROUND: In Gondar University Teaching Hospital standardized tuberculosis prevention and control programme, incorporating Directly Observed Treatment, Short Course (DOTS) started in 2000. According to the proposal of World Health Organization (WHO), treatment outcome is an important indicator of tuberculosis control programs. This study investigated the outcome of tuberculosis treatment at Gondar University Teaching Hospital in Northwest Ethiopia. METHODS: We analyzed the records of 4000 tuberculosis patients registered at Gondar University Teaching Hospital from September 2003 to May 2008. Treatment outcome and tuberculosis type were categorized according to the national tuberculosis control program guideline. Multivariate analysis using logistic regression model was used to analyse the association between treatment outcome and potential predictor variables. RESULTS: From the total of 4000 patients, tuberculosis type was categorized as extrapulmonary in 1133 (28.3%), smear negative pulmonary tuberculosis in 2196 (54.9%) and smear positive pulmonary tuberculosis in 671 (16.8%) cases. Of all patients, treatment outcome was classified as successfully treated in 1181(29.5%), defaulted in 730 (18.3%), died in 403 (10.1%), treatment failed in six (0.2%) and transferred out in 1680 (42.0%) patients. Males had the trend to be more likely to experience death or default than females, and the elderly were more likely to die than younger. The proportion of default rate was increased across the years from 97(9.2%) to 228(42.9%). Being female, age group 15-24 years, smear positive pulmonary tuberculosis and being urban resident were associated with higher treatment success rate. CONCLUSION: The treatment success rate of tuberculosis patients was unsatisfactorily low (29.5%). A high proportion of patients died (10.1%) or defaulted (18.3%), which is a serious public health concern that needs to be addressed urgently.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, only a few studies have been conducted to assess the treatment outcome of TB patients in northern Ethiopia [7,9].”
From Treatment success rate of tuberculosis patients in Dabat, northwest Ethiopia (2014) · cites this paper as [9]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553
Global Tuberculosis Control 2011, WHO Report 2011
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,022
Frieden, T. R., Sterling, T. R., Munsiff, S. S., Watt, C. J., & Dye, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14333-4 · Cited by 689
The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis
Weis, S. E., Slocum, P. C., Blais, F. X., King, B., Nunn, M., Matney, G. B., Gomez, E., & FORESMAN, B. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301702 · Cited by 588
Global tuberculosis control: surveillance planning financing. WHO report 2008.
Dye, C., Floyd, K., & Uplekar, M. (2008) · Cited by 575
When Tuberculosis Treatment Fails: A Social Behavioral Account of Patient Adherence
Sumartojo, E. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1311 · Cited by 463
Siddiqi, K., Lambert, M., & Walley, J. D. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00609-1 · Cited by 354
Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa
Mukadi, Y. D., Maher, D., & Harries, A. D. (2001) · AIDS · doi:10.1097/00002030-200101260-00002 · Cited by 311
Chaulk, C. P. (1998) · JAMA · doi:10.1001/jama.279.12.943 · Cited by 272
Worldwide Incidence of Multidrug‐Resistant Tuberculosis
Dye, C., Espinal, M., Watt, C. J., Mbiaga, C., & Williams, B. G. (2002) · The Journal of Infectious Diseases · doi:10.1086/339818 · Cited by 266
Barnhoorn, F., & Adriaanse, H. P. (1992) · Social Science & Medicine · doi:10.1016/0277-9536(92)90271-q · Cited by 203
Management of tuberculosis : a guide for low income countries
Enarson, D. A., Rieder, H. L., Arnadottir, T., & Trébucq, A. (2000) · Cited by 200
Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia
Elliott, A. M., Namaambo, K. M., Allen, B. W., Luo, N. P., Hayes, R., Pobee, J. O. M., & Mcadam, K. P. W. J. (1993) · Tubercle and Lung Disease · doi:10.1016/0962-8479(93)90010-u · Cited by 191
Veen, J., Raviglione, M. C., Rieder, H. L., Migliori, G. B., Gräf, P., Grzemska, M., & Zalesky, R. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12020505 · Cited by 164
Community tuberculosis care through “TB clubs” in rural North Ethiopia
Demissie, M., Getahun, H., & Lindtjørn, B. (2003) · Social Science & Medicine · doi:10.1016/s0277-9536(02)00182-x · Cited by 140
Use of Mycobacterial Smears in the Diagnosis of Pulmonary Tuberculosis in AIDS/ARC Patients
Klein, N. C., Duncanson, F. P., Lenox, T. H., Pitta, A., Cohen, S. C., & Wormser, G. P. (1989) · CHEST Journal · doi:10.1378/chest.95.6.1190 · Cited by 134
Shargie, E. B., & Lindtjørn, B. (2005) · BMC Public Health · doi:10.1186/1471-2458-5-62 · Cited by 97
The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis
Nunn, P., Mungai, M., Nyamwaya, J., Gicheha, C. M., Brindle, R. J., Dunn, D. T., Githui, W. A., Were, J. O., & Mcadam, K. P. W. J. (1994) · Tubercle and Lung Disease · doi:10.1016/0962-8479(94)90098-1 · Cited by 90
Current status of treatment completion and fatality among tuberculosis patients in Spain.
Caylà, J. A., Caminero, J. A., Rey, R. D., Lara, N., Vallès, X., & Galdós-Tangüis, H. (2004) · PubMed · Cited by 85
Outcome of patients treated for tuberculosis in Vaud County, Switzerland.
Zellweger, J. P., & Coulon, P. (1998) · PubMed · Cited by 66
Liefooghe, R., Suetens, C., Meulemans, H., Moran, M. B., & Muynck, A. D. (1999) · PubMed · Cited by 64
Dick, J., & Lombard, C. J. (1997) · PubMed · Cited by 63
Kassu, A., Mengistu, G., Ayele, B. A., Diro, E., Mekonnen, F., Ketema, D., Moges, F., Mesfin, T., Getachew, A., Ergicho, B., et al. (2007) · PubMed · Cited by 60
Exploring the determinants of treatment success for tuberculosis cases in Europe.
Falzon, D., Strat, Y. L., Belghiti, F. A. E., & Infuso, A. (2005) · PubMed · Cited by 45
The impact of intensified supervisory activities on tuberculosis treatment
Jin, B. W., Kim, S. C., Mori, T., & Shimao, T. (1993) · Tubercle and Lung Disease · doi:10.1016/0962-8479(93)90053-z · Cited by 41
(1954) · JAMA · doi:10.1001/jama.1954.02950160032013 · Cited by 41
Treatment Outcome of Pulmonary Tuberculosis in Eastern Taiwan—Experience at a Medical Center
Lee, J., Wu, R.-L., Lee, Y.-S., Wu, Y.-C., & Chiang, C. (2007) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60212-6 · Cited by 34
True status of smear-positive pulmonary tuberculosis defaulters in Malawi.
Kruyt, M. L., Kruyt, N. D., Boeree, M. J., Harries, A. D., Salaniponi, F. M. L., & van Noord, P. A. (1999) · Europe PMC (PubMed Central) · Cited by 33
Tuberculosis in rural northwest Ethiopia: community perspective.
Getahun, H., & Aragaw, D. (2001) · PubMed · Cited by 29
Harries, A. D., Mbewe, L. N., Salaniponi, F. M. L., Nyangulu, D. S., Veen, J., Ringdal, T., & Nunn, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90874-0 · Cited by 27
Aj, W., Cm, R.-W., & Luitel, H. (1999) · PubMed · Cited by 10
Research works printed but not linked: 10
- World Health Organisation (WHO): The world health report 2004: changing history. 2004, Geneva WHO
- Mukadi YD, Maher D, Harries A: Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS. 2001, 15: 143-152. 10.1097/00002030-200101260-00002. · DOI
- Chaulk CP, Kazandjian VA: Directly observed therapy for treatment completion of pulmonary tuberculosis. Consensus statement of the public health tuberculosis guidelines panel. JAMA. 1998, 279: 943-8. 10.1001/jama.279.12.943. · DOI
- Weis SE, Slocum PC, Blais FX: The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994, 330: 1179-84. 10.1056/NEJM199404283301702. · DOI
- World Health Organization (WHO): Global Tuberculosis Control. WHO Report 2001. WHO/CDS/TB/2001. 2001, 287: 1-181.
- Harries AD, Nyong'Onya Mbewe L, Salaniponi FML: programme changes and treatment outcomes in patients with smear-positive tuberculosis in Blantyre, Malawi. Lancet. 1996, 347: 807-809. 10.1016/S0140-6736(96)90874-0. · DOI
- Klein NC, Duncanson FP, Lenox TH, Pitta A, Cohen SC, Wormser GP: Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest. 1989, 95: 1190-1192. 10.1378/chest.95.6.1190. · DOI
- Elliott AM, Namaambo K, Allen BW, Luo N, Hayes RJ, Pobee JO, McAdam KP: Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuberc Lung Dis. 1993, 74: 191-194. 10.1016/0962-8479(93)90010-U. · DOI
- Nunn P, Mungai M, Nyamwaya J, Gicheha C, Brindle RJ, Dunn DT, Githui W, Were JO, McAdam KP: The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. Tuberc Lung Dis. 1994, 75: 25-32. 10.1016/0962-8479(94)90098-1. · DOI
- Siddiqi K, Lambert ML, Walley J: Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis. 2003, 3: 288-296. 10.1016/S1473-3099(03)00609-1. · DOI
Cited by
Sorted by citations
Journal of Pharmaceutical and Biomedical Sciences
(2016) · Journal of Pharmaceutical and Biomedical Sciences · doi:10.20936/jpbms · Cited by 193
Berhe, G., Enquselassie, F., & Aseffa, A. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-537 · Cited by 146
Tesfahuneygn, G., Medhin, G., & Legesse, M. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1452-x · Cited by 143
Gebrezgabiher, G., Romha, G., Ejeta, E., Asebe, G., Zemene, E., & Ameni, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150560 · Cited by 129
Getahun, B., Ameni, G., Medhin, G., & Biadgilign, S. (2013) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2012.12.010 · Cited by 100
Metadata
- Authors
- Tessema, B., Muche, A., Bekele, A., Reissig, D., Emmrich, F., & Sack, U.
- Affiliations
- University of Gondar (ET)
- Leipzig University (DE)
- Fraunhofer Institute for Cell Therapy and Immunology (DE)
- Corresponding author
- Tessema, Belay
- Venue
- BMC Public Health
- Published
- 2009-10-04
- Volume
- 9
- Issue
- 1
- Pages
- 371-371
- ISSN
- 1471-2458 (ISSN-L)
- PMC
- PMC2765962
- OpenAlex
- W2059980350
- Cited by
- 154
- References
- 32
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 3 · 2023: 2 · 2022: 6 · 2021: 8 · 2020: 4 · 2019: 15 · 2018: 26 · 2017: 10 · 2016: 22 · 2015: 13 · 2014: 16 · 2013: 13 · 2012: 3
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) (submittedVersion, other-oa)
- Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
- Greater South Information System
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Keywords
- tuberculosis, treatment outcomes, DOTS, treatment default, tuberculosis mortality, smear-negative tuberculosis, extrapulmonary tuberculosis, sex differences, age differences, urban residence, predictors of treatment success
- MeSH terms
- Adolescent, Adult, Aged, Antitubercular Agents, Child, Child, Preschool, Ethiopia, Hospitals, Teaching, Humans, Infant, Middle Aged, Patient Compliance, Retrospective Studies, Tuberculosis, Treatment Outcome, Treatment Failure, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
